Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Breaks, Double-Stranded | 2 | 2020 | 26 | 1.330 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2022 | 131 | 0.870 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 22 | 0.850 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 166 | 0.840 |
Why?
|
| MPTP Poisoning | 1 | 2020 | 3 | 0.710 |
Why?
|
| Brain | 3 | 2021 | 739 | 0.710 |
Why?
|
| Postmortem Changes | 1 | 2020 | 5 | 0.700 |
Why?
|
| Parkinson Disease | 1 | 2020 | 46 | 0.670 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 218 | 0.580 |
Why?
|
| Inflammation | 6 | 2024 | 626 | 0.520 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 677 | 0.520 |
Why?
|
| Glycoside Hydrolases | 1 | 2013 | 4 | 0.430 |
Why?
|
| Biotechnology | 1 | 2013 | 16 | 0.430 |
Why?
|
| Animals | 10 | 2024 | 10399 | 0.420 |
Why?
|
| Fungal Proteins | 1 | 2013 | 82 | 0.410 |
Why?
|
| Mice | 7 | 2024 | 4645 | 0.390 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2024 | 67 | 0.360 |
Why?
|
| DNA Repair | 2 | 2020 | 83 | 0.320 |
Why?
|
| Dopaminergic Neurons | 2 | 2020 | 16 | 0.320 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 485 | 0.320 |
Why?
|
| Biomarkers | 3 | 2022 | 755 | 0.310 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 1461 | 0.300 |
Why?
|
| Protein Kinases | 3 | 2024 | 158 | 0.270 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2022 | 48 | 0.240 |
Why?
|
| Fibrosis | 2 | 2021 | 133 | 0.220 |
Why?
|
| Lactates | 1 | 2024 | 19 | 0.220 |
Why?
|
| Dasatinib | 1 | 2022 | 18 | 0.200 |
Why?
|
| Quercetin | 1 | 2022 | 14 | 0.200 |
Why?
|
| Insulin Resistance | 1 | 2024 | 176 | 0.190 |
Why?
|
| Neurons | 1 | 2024 | 282 | 0.190 |
Why?
|
| Liver | 2 | 2021 | 434 | 0.190 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 87 | 0.190 |
Why?
|
| Cellular Senescence | 1 | 2022 | 125 | 0.180 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2020 | 2 | 0.180 |
Why?
|
| Substantia Nigra | 1 | 2020 | 5 | 0.180 |
Why?
|
| Corpus Striatum | 1 | 2020 | 23 | 0.170 |
Why?
|
| Cricetulus | 1 | 2020 | 56 | 0.170 |
Why?
|
| Estrogens | 1 | 2020 | 56 | 0.170 |
Why?
|
| CHO Cells | 1 | 2020 | 97 | 0.170 |
Why?
|
| DNA End-Joining Repair | 1 | 2019 | 3 | 0.170 |
Why?
|
| Homologous Recombination | 1 | 2019 | 10 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 112 | 0.160 |
Why?
|
| Mice, Knockout | 1 | 2022 | 845 | 0.160 |
Why?
|
| Genetic Testing | 1 | 2019 | 68 | 0.160 |
Why?
|
| Hippocampus | 1 | 2020 | 189 | 0.150 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 509 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 1570 | 0.150 |
Why?
|
| Monocrotophos | 1 | 2018 | 1 | 0.150 |
Why?
|
| DNA Damage | 1 | 2019 | 149 | 0.150 |
Why?
|
| Insecticides | 1 | 2018 | 7 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 135 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 372 | 0.150 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 58 | 0.140 |
Why?
|
| Cells, Cultured | 1 | 2020 | 985 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 121 | 0.140 |
Why?
|
| Oxidative Stress | 2 | 2021 | 663 | 0.140 |
Why?
|
| Aging | 2 | 2021 | 976 | 0.110 |
Why?
|
| Enzyme Stability | 1 | 2013 | 31 | 0.110 |
Why?
|
| Chitosan | 1 | 2013 | 34 | 0.110 |
Why?
|
| Substrate Specificity | 1 | 2013 | 151 | 0.100 |
Why?
|
| Humans | 3 | 2024 | 28121 | 0.090 |
Why?
|
| Glucose | 2 | 2024 | 203 | 0.080 |
Why?
|
| Fructose | 1 | 2024 | 22 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2024 | 21 | 0.050 |
Why?
|
| Cell Death | 1 | 2024 | 118 | 0.050 |
Why?
|
| Paralysis | 1 | 2022 | 10 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 136 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 70 | 0.050 |
Why?
|
| Cholesterol | 1 | 2024 | 200 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2024 | 184 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2022 | 44 | 0.050 |
Why?
|
| Cell Line | 1 | 2024 | 694 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2021 | 273 | 0.040 |
Why?
|
| Phenotype | 1 | 2022 | 679 | 0.040 |
Why?
|
| Mitochondria | 1 | 2022 | 366 | 0.040 |
Why?
|
| Toxicity Tests, Acute | 1 | 2018 | 1 | 0.040 |
Why?
|
| Memory, Long-Term | 1 | 2018 | 2 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 25 | 0.040 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2018 | 20 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 54 | 0.040 |
Why?
|
| Chemotaxis | 1 | 2018 | 28 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2018 | 22 | 0.040 |
Why?
|
| Obesity | 1 | 2024 | 668 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2018 | 42 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 112 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2018 | 55 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 163 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 153 | 0.030 |
Why?
|